Literature DB >> 21609323

Differential functions of phospholipid binding and palmitoylation of tumour suppressor EWI2/PGRL.

Bo He1, Yanhui H Zhang, Mekel M Richardson, Julian S Zhang, Eric Rubinstein, Xin A Zhang.   

Abstract

The tumour suppressor EWI2 associates with tetraspanins and regulates tumour cell movement and proliferation. The short cytoplasmic domain of EWI2 is positively charged; five out of the ten residues of this domain are basic. In the present study we demonstrated that the EWI2 cytoplasmic tail interacts specifically with negatively charged PIPs (phosphatidylinositol phosphates), but not with other membrane lipids. The PIPs that interact with EWI2 cytoplasmic tail include PtdIns5P, PtdIns4P, PtdIns3P, PtdIns(3,5)P(2) and PtdIns(3,4)P2. The binding affinity of PIPs to the EWI2 tail, however, is not solely based on charge because PtdIns5P, PtdIns4P and PtdIns3P have a higher affinity to EWI2 than PtdIns(3,5)P(2) and PtdIns(3,4)P(2) do. Mutation of either of two basic residue clusters in the EWI2 cytoplasmic tail abolishes PIP binding, and PIP binding is also determined by the position of basic residues in the EWI2 cytoplasmic tail. In addition, EWI2 is constitutively palmitoylated at the cytoplasmic cysteine residues located at the N-terminal of those basic residues. The PIP interaction is not required for, but appears to regulate, the palmitoylation, whereas palmitoylation is neither required for nor regulates the PIP interaction. Functionally, the PIP interaction regulates the stability of EWI2 proteins, whereas palmitoylation is needed for tetraspanin-EWI2 association and EWI2-dependent inhibition of cell migration and lamellipodia formation. For cell-cell adhesion and cell proliferation, the PIP interaction functions in opposition to the palmitoylation. In conclusion, the EWI2 cytoplasmic tail actively engages with the cell membrane via PIP binding and palmitoylation, which play differential roles in EWI2 functions. © The Authors Journal compilation
© 2011 Biochemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21609323      PMCID: PMC4141501          DOI: 10.1042/BJ20101381

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins.

Authors:  X A Zhang; A L Bontrager; M E Hemler
Journal:  J Biol Chem       Date:  2001-04-26       Impact factor: 5.157

Review 2.  Tetraspanins.

Authors:  C Boucheix; E Rubinstein
Journal:  Cell Mol Life Sci       Date:  2001-08       Impact factor: 9.261

Review 3.  The tetraspanin web modulates immune-signalling complexes.

Authors:  Shoshana Levy; Tsipi Shoham
Journal:  Nat Rev Immunol       Date:  2005-02       Impact factor: 53.106

Review 4.  Location, location, location: membrane targeting directed by PX domains.

Authors:  T K Sato; M Overduin; S D Emr
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

5.  Phosphatidic acid-mediated mitogenic activation of mTOR signaling.

Authors:  Y Fang; M Vilella-Bach; R Bachmann; A Flanigan; J Chen
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

Review 6.  Structural properties of lipid-binding sites in cytoskeletal proteins.

Authors:  V Niggli
Journal:  Trends Biochem Sci       Date:  2001-10       Impact factor: 13.807

7.  EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily.

Authors:  C S Stipp; T V Kolesnikova; M E Hemler
Journal:  J Biol Chem       Date:  2001-08-14       Impact factor: 5.157

Review 8.  Biophysics of ceramide signaling: interaction with proteins and phase transition of membranes.

Authors:  M Krönke
Journal:  Chem Phys Lipids       Date:  1999-08       Impact factor: 3.329

9.  PGRL is a major CD81-associated protein on lymphocytes and distinguishes a new family of cell surface proteins.

Authors:  K L Clark; Z Zeng; A L Langford; S M Bowen; S C Todd
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

10.  FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein.

Authors:  C S Stipp; D Orlicky; M E Hemler
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

View more
  8 in total

Review 1.  The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.

Authors:  Gerwyn Morris; Ken Walder; Basant K Puri; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

2.  Distinct palmitoylation events at the amino-terminal conserved cysteines of Env7 direct its stability, localization, and vacuolar fusion regulation in S. cerevisiae.

Authors:  Surya P Manandhar; Erika N Calle; Editte Gharakhanian
Journal:  J Biol Chem       Date:  2014-03-07       Impact factor: 5.157

3.  IGSF3 mutation identified in patient with severe COPD alters cell function and motility.

Authors:  Kelly S Schweitzer; Natini Jinawath; Raluca Yonescu; Kevin Ni; Natalia Rush; Varodom Charoensawan; Irina Bronova; Evgeny Berdyshev; Sonia M Leach; Lucas A Gillenwater; Russel P Bowler; David B Pearse; Constance A Griffin; Irina Petrache
Journal:  JCI Insight       Date:  2020-07-23

4.  EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation.

Authors:  Chenying Fu; Jie Wang; Sandeep Pallikkuth; Yingjun Ding; Junxiong Chen; Jonathan D Wren; Yuchao Yang; Kwong-Kwok Wong; Hiroyasu Kameyama; Muralidharan Jayaraman; Anupama Munshi; Takemi Tanaka; Keith A Lidke; Xin A Zhang
Journal:  Cell Mol Life Sci       Date:  2022-06-30       Impact factor: 9.207

5.  Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease.

Authors:  Junmei Wan; Jeffrey N Savas; Amy F Roth; Shaun S Sanders; Roshni R Singaraja; Michael R Hayden; John R Yates; Nicholas G Davis
Journal:  Chem Biol       Date:  2013-11-07

6.  EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer.

Authors:  Jie Wang; Jonathan D Wren; Yingjun Ding; Junxiong Chen; Nikhil Mittal; Chao Xu; Xing Li; Cengxi Zeng; Meng Wang; Jing Shi; Yanhui H Zhang; Sangyoon J Han; Xin A Zhang
Journal:  Cancer Lett       Date:  2022-03-24       Impact factor: 9.756

7.  EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis.

Authors:  Chenying Fu; Qing Zhang; Ani Wang; Songpeng Yang; Yangfu Jiang; Lin Bai; Quan Wei
Journal:  Mol Oncol       Date:  2021-03-27       Impact factor: 6.603

8.  Tetraspanin-enriched microdomains regulate digitation junctions.

Authors:  Chao Huang; Chenying Fu; Jonathan D Wren; Xuejun Wang; Feng Zhang; Yanhui H Zhang; Samuel A Connel; Taosheng Chen; Xin A Zhang
Journal:  Cell Mol Life Sci       Date:  2018-03-27       Impact factor: 9.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.